Ernest B. Remo,  Chairman and CEO of ADHC Mr. Remo

New Post Public Reply Private Reply Replies (1) Message Board
John Howard

Ernest B. Remo,  Chairman and CEO of ADHC

Mr. Remo whose career in Wall Street spanned thirty years where he was involved in all areas of the institutional bond and equity business. After starting at the bond underwriting firm of Halsey, Stuart & Co., Inc., he later was associated with Oppenheimer & Company in New York, Montgomery Securities in San Francisco and finished in New York at Scotia McLeod where he was Manager, U.S. Equity Sales and Research and finally at Nikko Securities where he served as Chairman. Investment Policy Committee.

Mr. Remo has served on the boards of various public companies, including being Chairman of Icon Laser Eye Centers, a Toronto based and TSE listed eye surgery company and Chairman of the Audit Committee of Vision America, a Memphis based and Nasdaq listed ophthalmic practice management company. He was also Chairman/CEO of Eyemakers, Inc., a Dallas, Texas based optometric practice management and Lasik clinic operator.

Mr. Remo's extensive activity in the medical area also included being Chairman of IGEA Salus, a Rome, Italy based operator of dialysis clinics and finally as Chairman/CEO of ADHC.

Mr. Remo has also acted as an advisor to a number of other companies, both public and private and is now concentrating his efforts, through ADHC, to finding new medical treatment of disease through the uses of Stem Cell research and therapy.


American Diversified Holdings Corp. (ADHC) Stock Research Links

ADHC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Brixton Metals Expands Thorn Project with New Mineral Claims

Updated Category News Views 198

Brixton Metals Expands Thorn Project with New Mineral Claims Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) has expanded its footprint at the Thorn Project, securing a 100% interest in mineral claims covering 6,446 hectares. These claims, which were previously outside Brixton’s control, sit northwest of the well-known Golden Bear Mine and add ground the company...

Continue Reading
Nutex Health Awaits Q2 Results Amid Regulatory Hurdles

Updated Category News Views 20

Diving headfirst into the grumbles of this healthcare whirlwind we call Nutex Health. They've set the table to drop their Q2 financials on August 6, right after the bell, followed by a chat with investors the next morning. We're talking bumper-to-bumper business news here, and everyone with a slice in NASDAQ: NUTX better have their ears pricked. Nutex Health: A Mixed Bag...

Continue Reading
Arvore Partners LP Announces Impressive October Distribution

Updated Category News Views 183

Arvore Partners LP Declares Monthly Distribution for October Arvore Partners LP is thrilled to share details about the declaration of its monthly distribution for October. This distribution amounts to $687,365, which translates to an impressive 9.06% annualized yield for its unitholders, marking a 7% increase from the previous month. This consistent growth highlights...

Continue Reading
Key Insights on Marathon Petroleum's Upcoming Earnings Call

Updated Category News Views 101

An Overview of Marathon Petroleum's Earnings Expectations Marathon Petroleum (NYSE: MPC) is gearing up for its quarterly earnings announcement. Investors should prepare for necessary insights leading up to the release of this important announcement. Analysts predict a solid earnings per share (EPS) of $3.23 for the upcoming quarter. While it’s crucial for the company to...

Continue Reading
Revolutionizing Male Infertility Research with PacBio's Revio

Updated Category News Views 80

Transforming Male Infertility Research with PacBio's Revio MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading name in sequencing solutions, is launching an exciting collaboration with the University Hospital of Münster. This partnership is set to leverage long-read whole genome sequencing to significantly advance research in male infertility and rare diseases....

Continue Reading